The success of Viagra initially fueled a surge for pharma, however recent changes present a murky outlook for shareholders. Off-patent alternatives are reducing profits, and ongoing patent challenges add additional https://saulumht868024.mybjjblog.com/sildenafil-and-big-pharma-a-precarious-investment-53361084